Breast Cancer Clinical Trial
Comparison of Three Methods for Early Detection of Breast Cancer
Summary
Subjects with suspicious breast lesion (BIRADS category 4/5) who are scheduled to undergo biopsy will be recruited to undergo imaging evaluation with Contrast Enhanced Dual Energy Mammography (CEDM), Contrast Enhanced Breast MR (CEMR) and Contrast Enhanced Ultrasound (CEUS).
Full Description
The co-primary endpoints are to estimate the sensitivity and specificity of CEUS relative to pathology determined diagnosis.
Positive predictive value of CEDM in detecting lesions seen on MR
Estimate the negative predictive value (TN/(TN+FN)) of CEUS as an adjunct.
Compare the frequency of recommendation of biopsy of MG±US vs MG±US plus CEUS as an adjunct based on BIRADS scores.
Comparison of background enhancement seen on CEUS with that seen on CEDM and CEMR.
Eligibility Criteria
Inclusion Criteria:
Provision of signed and dated informed consent form
Stated willingness to comply with all study procedures and availability for the duration of the study
Patients, greater than 30 years of age
In good general health as evidenced by medical history
BIRADS 4 or 5 suspicious breast lesions who are scheduled for breast biopsy.
Exclusion Criteria:
Patients who are less than 30 years of age
Have known or suspected cardiac shunts
Have history of hypersensitive allergic reactions to any imaging contrast agents
Pregnant (a urine pregnancy test will be given at no cost to the patient)
Are nursing babies
Poor renal function
Are unwilling or unable (such as having a pacemaker) to undergo a CEMR
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There is 1 Location for this study
Rochester Minnesota, 55905, United States
How clear is this clinincal trial information?
Please confirm you are a US based health care provider:
Yes, I am a health care Provider No, I am not a health care providerSign Up Now.
Take Control of Your Disease Journey.
Sign up now for expert patient guides, personalized treatment options, and cutting-edge insights that can help you push for the best care plan.